| Literature DB >> 34681002 |
Yazmín Hernández-Díaz1, Alma Delia Genis-Mendoza2, Thelma Beatriz González-Castro1, Carlos Alfonso Tovilla-Zárate3, Isela Esther Juárez-Rojop4, María Lilia López-Narváez5, Humberto Nicolini2.
Abstract
BACKGROUND: Suicide behavior (SB) has been highly associated with the response to stress and the hypothalamic-pituitary-adrenal (HPA) axis. The aim of this study was to summarize the results obtained in genetic studies that analyzed the HPA axis-stress pathway and SB through a systematic review.Entities:
Keywords: association; genetic; stress; suicide
Mesh:
Year: 2021 PMID: 34681002 PMCID: PMC8536196 DOI: 10.3390/genes12101608
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Figure 1Representative image of HPA axis and the stress pathway genes implicated in suicide behavior. Upon perception of stress, CRH is released from the hypothalamus, which promotes the synthesis and release of ACTH from the pituitary. ACTH, in turn, increases the release of cortisol from the adrenal glands. Through negative feedback, cortisol inhibits the hormone release from the hypothalamus and anterior pituitary glands. Inside the cell, cortisol causes the activation of molecular mechanisms that regulate the impact of the HPA axis.
Figure 2PRISMA flow chart presenting the articles identification and selection processes.
Detailed analysis of the selected publications regarding the association between single-nucleotide polymorphisms (SNP) in HPA genes and the pathogenesis of suicide behavior.
| Author, Year | Chromosome | SNP | Location | Substitution | Diagnostic | Suicide Behavior | Population Data (N) | Measurement on Trauma Exposure | Tissue Source | Main Outcomes | |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
| ||||||||||
|
| |||||||||||
| Papiol, S. 2007 [ | 6 | rs1360780 | Intron | T > C | MDD | SA | 24 | 96 | - | Blood | T allele carriers showed 2.10 increased for non-responding to citalopram treatment at week 4 |
| Willour, V. L. 2009 [ | 6 | rs1043805 | 3’UTR | T > A | BD | SA | 544 | - | - | - | Four SNPs showed significant associations with SA: rs1043805, rs3800373, rs9296158 and rs1360780. |
| rs3800373 | 3′UTR | C > A | |||||||||
| rs7757037 | Intron | G > A | |||||||||
| rs3798346 | Intron | A > G | |||||||||
| rs9296158 | Intron | G > A | |||||||||
| rs1360780 | Intron | T > A | |||||||||
| rs4713902 | Intron | T > C | |||||||||
| rs6912833 | Intron | A > T | |||||||||
| rs9380525 | Intron | G > A | |||||||||
| Brent, D. 2010 [ | 6 | rs3800373 | 3′UTR | C > A | MDD | SB | 18 | - | - | Blood and Buccal | Genotypes of rs1360780TT and rs3800373GG were associated with SB, even after controlling for treatment effects and relevant covariates. |
| rs1360780 | Intron | T > A | |||||||||
| Roy, A. 2010 [ | 6 | rs3800373 | 3′UTR | C > A | SUD | SA | 248 | 1465 | CTQ | Blood | 1. Three SNPs showed significant associations with SA: rs3777747, rs4713902, and rs9470080. |
| rs9470065 | Intron | G > A | |||||||||
| rs9296158 | Intron | G > A | |||||||||
| rs4713899 | Intron | G > A | |||||||||
| rs9470067 | Intron | G > A | |||||||||
| rs3777747 | Intron | G > A | |||||||||
| rs7762668 | Intron | G > A | |||||||||
| rs9462099 | Intron | T > C | |||||||||
| rs9380524 | Intron | C > A | |||||||||
| rs1360780 | Intron | T > C | |||||||||
| rs7771722 | Intron | G > A | |||||||||
| rs4713902 | Intron | T > C | |||||||||
| rs9462100 | Intron | T > C | |||||||||
| rs2092427 | Intron | G > A | |||||||||
| rs7762760 | Intron | G > A | |||||||||
| rs9470080 | Intron | T > C | |||||||||
| Perroud, N. 2011 [ | 6 | rs1360780 | Intron | T > C | DE | SI | 131 | - | - | - | The T allele was a risk factor of SI and it was associated with the response to antidepressant treatment. |
| Supriyanto, I. 2011 [ | 6 | rs3800373 | 3′UTR | C > A | SV | CS | 219 | 228 | - | Blood | No association. |
| rs1360780 | Intron | T > C | |||||||||
| rs2395635 | Intron | A > C | |||||||||
| Roy, A. 2012 [ | 6 | rs3800373 | 3′UTR | C > A | SUD | SA | 141 | 689 | CTQ | Blood | 1. In the group exposed to severe trauma, the prevalence of SA was 0.49 in carriers of the major homozygote. |
| Leszczynska-Rodziewicz, A. 2014 [ | 6 | rs1360780 | Intron | T > C | BD | SA | 156 | 724 | - | Blood | No association. |
| rs755658 | Intron | C > T | |||||||||
| rs4713916 | Intron | A > G | |||||||||
| rs7748266 | Intron | T > C | |||||||||
| rs9296158 | Intron | G >A | |||||||||
| rs9394309 | Intron | G >A | |||||||||
| rs9470080 | Intron | T > A | |||||||||
| rs3800373 | 3′UTR | C > A | |||||||||
| Breen, M. E. 2015 [ | 6 | rs6926133 | Intron | A > C | BD | SA | 631 | 657 | ELES | - | No association. |
| rs12200498 | Intron | G > A | |||||||||
| rs9380526 | Intron | C > T | |||||||||
| rs16879378 | Intron | A > C | |||||||||
| rs4713899 | Intron | G > A | |||||||||
| Fudalej, S. 2015 [ | 6 | rs3800373 | 3′UTR | C > A | SV | CS | 520 | 475 | - | Blood | A significant association between the high-induction rs3800373 C allele and SV was detected. |
| rs1360780 | Intron | T > C | |||||||||
| Breen, M. E. 2016 [ | 6 | rs141713011 | Intron/3′UTR | G > T | BD or SD | SA | 476 | 473 | - | - | rs141713011 showed an excess of minor alleles in SA that was statistically significant following correction for multiple testing, but it could not be replicated. |
| rs140664762 | Intron/3′UTR | G > A | |||||||||
| rs575259136 | Intron | A > AAAG | |||||||||
| rs13192954 | Intron | A > G | |||||||||
| rs553156199 | 3′UTR | C > T | |||||||||
| Yin, H. 2016 [ | 6 | rs3800373 | 3′UTR | C > A | MDD | SA and CS | SA: 87 | SA: 190 | - | SA: - | 1. rs9296158, rs3777747, rs4713902, rs7757037, rs737054, and rs9380529 showed evidence of association at uncorrected |
| rs9296158 | Intron | A > C | |||||||||
| rs3777747 | Intron | A >G | |||||||||
| rs4713902 | Intron | T > C | |||||||||
| rs9470080 | Intron | T > A | |||||||||
| rs7757037 | Intron | G > A | |||||||||
| rs737054 | Intron | G > A | |||||||||
| rs9380529 | Intron | A > C | |||||||||
| Mirkovic, B. 2017 [ | 6 | rs1360780 | Intron | T > C | Mixed | SA | 98 | 150 | - | Saliva | No association. |
| rs3800373 | 3′UTR | C > A | |||||||||
| Segura, A. G. 2019 [ | 6 | rs3777747 | Intron | A >G | BD | SB | 129 | - | CTQ | Blood | 1. rs3777747AA and rs2766533GG genotypes were associated with SB. |
| rs1360780 | Intron | T >A | |||||||||
| rs17542466 | Intron | A > C | |||||||||
| rs2766533 | Intron | G > A | |||||||||
| Zhang, L. 2019 [ | 6 | rs1360780 | Intron | T > C | PTSD and DE | SI | 266 | 3623 | LEC | Saliva | No association. |
| rs9470080 | Intron | T > A | |||||||||
| rs3800373 | 3′UTR | C > A | |||||||||
| rs9296158 | Intron | A > C | |||||||||
| Nobile, B. 2020 [ | 6 | rs737054 | Intron | G > A | MDD | SI and SA | SI: 99SA:9 | 384 | - | Buccal | The TT genotype of rs737054 and TT genotype of rs6902321 were significantly associated with SI. These associations were not significant after multiple test corrections. |
| rs6902321 | Intron | C > T | |||||||||
| rs3800373 | 3′UTR | C > A | |||||||||
| rs7757037 | Intron | G > A | |||||||||
| rs1360780 | Intron | T > C | |||||||||
| rs9470080 | Intron | T > A | |||||||||
| Berent, D. 2020 [ | 6 | rs1360780 | Intron | T > C | AD | SA | 176 | 127 | ACE | Buccal | No association. |
| Hernández-Díaz, Y. 2021 [ | 6 | rs4713916 | Intron | A > G | SA | SA | 146 | 277 | - | Blood | 1. rs1360780 T minor allele was found to be a risk factor for SA. |
| rs1360780 | Intron | T > C | |||||||||
| rs4713902 | Intron | T > C | |||||||||
| rs3800373 | 3′UTR | C > A | |||||||||
| rs9296158 | Intron | A > C | |||||||||
|
| |||||||||||
| Wasserman, D. 2008 [ | 8 | rs1870393 | Intron | A > C | Mixed | SA | 542 | - | SLEI | Blood | No association. |
| rs3176921 | 5′ region | C > T | |||||||||
| De Luca, V. 2010 [ | 8 | rs3176921 | 5′ region | C > T | SZ | SA | 81 | 150 | - | Blood | No association. |
| Roy, A. 2012 [ | 8 | rs6996265 | Intron | A > G | SUD | SA | 141 | 689 | CTQ | Blood | No association. |
| rs3176921 | 5′ region | C > T | |||||||||
| rs6472257 | 5′ region | C > T | |||||||||
| rs5030875 | Intergenic | T > G | |||||||||
| Breen, M. E. 2015 [ |
| rs6990486 | Downstream | G > A | BD | SA | 631 | 657 | ELES | - | No association. |
| rs6472257 | Upstream | C > T | |||||||||
| rs7835214 | Downstream | T > C | |||||||||
| rs10957368 | Downstream | T > C | |||||||||
| rs10105164 | Downstream | C > T | |||||||||
|
| |||||||||||
| Papiol, S. 2007 [ | 5 | rs7728378 | Intron | C > T | MDD | SA | 24 | 96 | - | Blood | No association. |
| rs1875999 | 3′UTR | A > G | |||||||||
| De Luca, V. 2010 [ | 5 | rs1875999 | 3′UTR | A > G | SZ | SA | 81 | 150 | - | Blood | The heterozygous genotype was significantly associated with SA as a risk of attempt. |
| Roy, A. 2012 [ | 5 | rs3792738 | 5′UTR | C > A | SUD | SA | 141 | 689 | CTQ | Blood | rs6453267, rs7728378, and rs10474485 showed a nominally significant interaction with the continuous CTQ score to predict SA. 2. There was an additive effect of |
| rs328967 | Intron | A > G | |||||||||
| rs6453267 | Intron | G > A | |||||||||
| rs7728378 | Intron | C > T | |||||||||
| rs1875999 | 3′UTR | A > G | |||||||||
| rs10474485 | Intron | C > A | |||||||||
| rs1715747 | Intron | C > T | |||||||||
| rs1500 | Alt isoform | C > G | |||||||||
| Breen, M. E. 2015 [ | 5 | rs7721799 | Intron | G > A | BD | SA | 631 | 657 | ELES | - | No association. |
| rs2174444 | Downstream | C > T | |||||||||
| rs10473984 | Downstream | G > T | |||||||||
| Segura, A. G. 2019 [ | 5 | rs7728378 | Intron | C > T | BD | SB | 139 | - | CTQ | Blood | 1. rs7728378-C carriers were associated with SB. This association did not remain significant after correcting for multiple comparisons. |
| rs10474485 | Intron | C > A | |||||||||
|
| |||||||||||
| Papiol, S. 2007 [ | 17 | rs110402 | Intron | C > T | MDD | SA | 24 | 96 | - | Blood | TT homozygous had nearly 3 times more risk to develop seasonal pattern episodes. |
| rs242937 | Intron | A > C | |||||||||
| Wasserman, D. 2008 [ | 17 | rs1396862 | Intron | G > A | Mixed | SA | 542 | - | SLEI | Blood | Stratification based on the levels of lifetime stress showed reproducible association and linkage of rs4792887 to SA exposed to low levels of stress mainly in males who were depressed. |
| rs4792887 | Intron | C > T | |||||||||
| Wasserman, D. 2009 [ | 17 | rs4792887 | Intron | C > T | Mixed | SA | 672 | - | SLEI | Blood | 1. The minor T-allele of rs12936511 was significantly transmitted in males with SB and with increased BDI scores. |
| rs110402 | Intron | C > T | |||||||||
| rs12936511 | Exon | C > T | |||||||||
| rs242939 | Intron | A > G | |||||||||
| rs242938 | Intron | A > C | |||||||||
| rs1876831 | Intron | C > T | |||||||||
| rs16940665 | Exon | T > C | |||||||||
| rs4792887 | Intron | C > T | |||||||||
| rs110402 | Intron | C > T | |||||||||
| De Luca, V. 2010 [ | 17 | rs16940665 | Exon | T > C | SZ | SA | 81 | 150 | - | Blood | No association. |
| Ben-Efraim, Y. J. 2011 [ | 17 | rs4792887 | Intron | C > A | DE | SA | 284 | 354 | SLEI | - | 1. G×E predominantly in females with SA between rs7209436 and childhood/adolescence physical assault or attack. |
| rs110402 | Intron | C > T | |||||||||
| rs16940665 | Exon | T > C | |||||||||
| rs4792887 | Intron | C > T | |||||||||
| Roy, A. 2012 [ | 17 | rs9900679 | Intron | A > C | SUD | SA | 141 | 689 | CTQ | Blood | No association. |
| rs4792887 | Intron | C > T | |||||||||
| rs110402 | Intron | C > T | |||||||||
| rs249224 | Intron | C > A | |||||||||
| rs8072451 | Intron | C > T | |||||||||
| rs81189 | Intron | G > C | |||||||||
| rs24939 | Intron | A > G | |||||||||
| rs173365 | Intron | T > C | |||||||||
| rs17689918 | Intron | G > A | |||||||||
| Guillaume, S. 2013 [ | 17 | rs242948 | Downstream | C > T | Mixed | SA | 218 | - | CTQ | Blood | Sexual abuse and emotional neglect in childhood interacted with rs1396862, rs878886, and rs242948 to modulate adult decision making in SA. |
| rs1396862 | Intron | G > A | |||||||||
| rs878886 | 3′UTR | G > T | |||||||||
| rs4076452 | Intron | G > C | |||||||||
| Leszczynska-Rodziewicz, A. 2013 [ | 17 | rs4076452 | Intron | G > C | BD | SA | 225 | 712 | - | Blood | No association. |
| rs12936511 | Exon | C > T | |||||||||
| rs4792887 | Intron | C > T | |||||||||
| rs24290 | Intron | T > C | |||||||||
| rs878886 | 3′ UTR | G > T | |||||||||
| rs173365 | Intron | T > C | |||||||||
| rs110402 | Intron | C > T | |||||||||
| Breen, M. E. 2015 [ | 17 | rs2664008 | Intron | G > A | BD | SA | 631 | 657 | ELES | - | Significant interaction between rs2664008 and a history of childhood physical and/or sexual abuse was reported; however, this interaction was not significant after correcting for multiple testing. |
| rs1724425 | Intron | C > T | |||||||||
| rs1526123 | Intron | T > A | |||||||||
| rs6593447 | Intron | A > G | |||||||||
| rs11655764 | Intron | G > A | |||||||||
| Pawlak, J. 2016 [ | 17 | rs4792877 | Intron | A > G | AD | SA | 277 | 847 | - | Blood | rs16940665 polymorphism was associated with SA in MDD males. |
| rs12936511 | Exon | C > T | |||||||||
| rs110402 | Intron | C > T | |||||||||
| rs16940665 | Exon | T > C | |||||||||
| Mirkovic, B. 2017 [ | 17 | rs4792887 | Intron | C > T | Mixed | SA | 98 | 150 | - | Buccal | No association. |
| Bastos, C. R. 2017 [ | 17 | rs110402 | Intron | C > T | Mixed | SI and SA | SI: 15SA: 20 | 136 | - | Blood | Individuals who carried the A allele increased in 15% additional risk for SA via the increase in IL-1b levels. |
| Ludwig, B. 2018 [ | 17 | rs7209436 | Intron | C > T | AD | SA | 70 | 181 | CTQ and BLEQ | Blood | Significant gene-environment-interactions were found for the SNPs rs7209436 and rs110402, reflecting the impact of childhood trauma and CRHR1 gene polymorphisms in previous SA. |
| rs4792887 | Intron | C > T | |||||||||
| rs110402 | Intron | C > T | |||||||||
| rs242924 | Intron | C > A | |||||||||
| rs242939 | Intron | A > G | |||||||||
| Segura, A. G. 2019 [ | 17 | rs110402 | Intron | C > T | BD | SB | 129 | - | CTQ | Blood | No association. |
| rs242940 | Intron | A > G | |||||||||
| Sanabrais-Jiménez, M.A. 2019 [ | 17 | rs110402 | Intron | C > T | BD and MDD | SA | 183 | 183 | CTQ | Blood | The analysis showed an interaction of |
| rs242924 | Intron | C > A | |||||||||
| rs16940665 | Exon | T > C | |||||||||
| Nobile, B. 2020 [ | 17 | rs878886 | 3′UTR | G > T | MDD | SI and SA | SI: 99SA: 9 | 384 | - | Buccal | No association. |
|
| |||||||||||
| Papiol, S. 2007 [ | 7 | rs2240403 | Exon | C > T | MDD |
| 24 | 96 |
| Blood | Allele G carriers of rs2270007 showed a worse overall response to citalopram though time of follow-up and showed 2.93 increased risk for nonresponding to citalopram treatment at week 4. |
| rs2270007 | Intron | G > C | |||||||||
| De Luca, V. 2010 [ | 7 | rs1076292 | Intron | C > T | SZ | SA | 81 | 150 | Blood | No association | No association. |
| Roy, A. 2012 [ | 7 | rs3779250 | Intron | G > A | SUD | SA | 141 | 689 | CTQ | Blood | No association. |
| rs973002 | Intron | A > G | |||||||||
| rs8192498 | - | G > A | |||||||||
| rs2190242 | Intron | A > C | |||||||||
| rs2284217 | Intron | G > A | |||||||||
| rs2014663 | Intron | A > G | |||||||||
| rs6967702 | 5′ region | G > C | |||||||||
| rs4723002 | Intergenic | A > G | |||||||||
| rs255102 | Intergenic | T > A | |||||||||
| rs255105 | Intergenic | T > C | |||||||||
| rs255125 | Intergenic | G > A | |||||||||
| Guillaume, S. 2013 [ | 7 | rs255098 | Intron | G > A | Mixed | SA | 218 | - | CTQ | Blood | Sexual abuse and emotional neglect in childhood interacted with rs255098 to modulate adult decision making in SA. |
| rs2270007 | Intron | G > C | |||||||||
| Breen, M. E. 2015 [ | 7 | rs2267716 | Intron | T > C | BD | SA | 631 | 657 | ELES | - | No association. |
| rs11980048 | Intron | G > T | |||||||||
| rs4723002 | Intron | A > G | |||||||||
| rs2190242 | Intron | C > A | |||||||||
| rs4723003 | Intron | C > T | |||||||||
| Segura, A. G. 2019 [ | 7 | rs4722999 | Intron | C > T | BD | SB | 129 | - | CTQ | Blood | No association. |
| rs2284219 | Intron | A > G | |||||||||
| rs255115 | Intron | G > A | |||||||||
| rs255102 | Intergenic | T > A | |||||||||
| Sanabrais-Jiménez, M.A. 2019 [ | 7 | rs2190242 | Intron | C > A | BD and MDD | SA | 183 | 183 | CTQ | Blood | An interaction of |
| rs2284217 | Intron | G > A | |||||||||
| rs2014663 | Intron | A > G | |||||||||
|
| |||||||||||
| De Luca, V. 2010 [ | 5 | rs6196 | Exon | A > G | SZ | SA | 81 | 150 | - | Blood | This SNP was significantly associated with SA, positively protecting against suicide attempt. |
| Supriyanto, I. 2011 [ | 5 | rs6196 | Exon | A > G | - | CS | 219 | 228 | - | Blood | No association. |
| rs10052957 | Intron | G > A | |||||||||
| Leszczynska-Rodziewicz, A. 2013 [ | 5 | rs41423247 | Intron | G > C | BD | SA | 225 | 712 | - | Blood | No association. |
| rs6195 | Intron | T > C | |||||||||
| rs6198 | 3′UTR | T > C | |||||||||
| rs6191 | 3′UTR | C > A | |||||||||
| rs6196 | Exon | A > G | |||||||||
| rs33388 | Intron | A > G | |||||||||
| Breen, M. E. 2015 [ | 5 | rs4912905 | Intron | G > C | BD | SA | 631 | 657 | ELES | - | No association. |
| rs10042042 | Intron | G > A | |||||||||
| rs17209251 | Intron | A > G | |||||||||
| rs17100236 | Intron | T > C | |||||||||
| rs10477211 | Intron | A > G | |||||||||
| Yin, H. 2016 [ | 5 | rs6196 | Exon | A > G | MDD | SA and CS | SA: 87 | 190 | - | SA: - | rs9324924 showed evidence of association at uncorrected |
| rs33388 | Intron | A > C | |||||||||
| rs33389 | Intron | C > T | SV: 121 | 88 | SV: Brain | ||||||
| rs10052957 | Intron | G > A | |||||||||
| rs9324924 | Intron | G > A | |||||||||
| Park, S. 2016 [ | 5 | rs41423247 | Intron | G > C | Cancer | CS | 182 | 161 | - | SNP was associated with the susceptibility to suicide within the first year after cancer diagnosis. | |
| Segura, A. G. 2019 [ | 5 | rs6198 | 3′UTR | T > C | BD | SB | 129 | - | CTQ | Blood | No association. |
| rs2963156 | Intron | T > C | |||||||||
| rs1837262 | Intron | C > A | |||||||||
| rs4912910 | Intron | A > G | |||||||||
| rs4634384 | Intron | C > T | |||||||||
| Nobile, B. 2020 [ | 5 | rs2963155 | Intron | A > G | MDD | SI and SA | SI: 99 | 384 | - | Buccal | AG genotype of rs2963155 was associated with SI. This association was not significant after multiple test correction. |
| rs33388 | Intron | A > C | |||||||||
| rs4912905 | Intron | G > C | |||||||||
| rs41423247 | Intron | G > C | SA: 9 | ||||||||
| rs6189 | Exon | C > T | |||||||||
| rs12656106 | Intron | G > C | |||||||||
| rs4607376 | Intron | G > T | |||||||||
|
| |||||||||||
| Supriyanto, I. 2011 [ | 4 | rs5525 | Exon | A > C | CS | CS | 219 | 228 | - | Blood | No association. |
| rs5522 | Exon | C > T | |||||||||
| rs2070951 | 5′UTR | G > A | |||||||||
| Segura, A. G. 2019 [ | 4 | rs5534 | 3′UTR | T > C | BP | SB | 129 | - | CTQ | Blood | No association. |
| rs12499208 | Intron | T > C | |||||||||
| rs6846591 | Intron | T > C | |||||||||
| rs5522 | Exon | C > T | |||||||||
|
| |||||||||||
| Kaminsky, Z. 2015 [ | 17 | rs7208505 | 3′UTR | G > T | PTSD | SI and SA | SI: 325 | 658 | CTQ | Blood and Saliva | Significant interactions of SKA2 3′-UTR DNA methylation and rs7208505 genotype for SI and SA. |
| Yin, H. 2016 [ | 17 | rs8082544 | - | A > G | MDD | SA and CS | SA: 87SV: 121 | 190 | - | SA: - | 1. rs12945875, rs9911583, and rs8067682 showed evidence for association at uncorrected |
| rs12945875 | Intron | G > A | |||||||||
| rs9911583 | Intron | G > A | |||||||||
| rs8067682 | Intron | A > G | |||||||||
| rs7502947 | Intron | G > A | |||||||||
| Sadeh, N. 2016 [ | 17 | rs7208505 | 3′UTR | G > T | PTSD | SI, SP, SA | SI: 146 | - | - | Blood | No association. |
| Nobile, B. 2020 [ | 17 | rs7208505 | 3′UTR | G > T | MDD | SI and SA | SI: 99 | 384 | - | Buccal | GG/AG genotype was significantly associated with SI. This association was not significant after multiple test correction. |
|
| |||||||||||
| De Luca, V. 2010 [ | 18 | rs4797825 | 3′UTR | C > T | SZ | SA | 81 | 150 | - | Blood | No association. |
| Breen, M. E. 2015 [ | 18 | rs3744819 | 3′UTR | C > A | BD | SA | 631 | 657 | ELES | - | No association. |
| rs12456733 | Intron | G > A | |||||||||
| rs1941088 | Intron | G > A | |||||||||
| rs3888305 | 3′UTR | A > C | |||||||||
| rs4308014 | 3′UTR | C > T | |||||||||
| Segura, A. G. 2019 [ | 18 | rs4797825 | 3′UTR | C > T | BD | SB | 129 | - | CTQ | Blood | No association. |
| rs9961110 | Intron | T > C | |||||||||
| rs17624314 | Intron | A > G | |||||||||
|
| |||||||||||
| Breen, M. E. 2015 [ | 2 | rs7565877 | intron | A > G | BD | SA | 631 | 657 | ELES | - | No association. |
| rs6545975 | intron | C > A | |||||||||
| rs7565427 | intron | A > C | |||||||||
| rs934778 | intron | A > G | |||||||||
| rs1866146 | Downstream | G > A | |||||||||
| Segura, A. G. 2019 [ | 2 | rs713586 | Intron | T > C | BD | SB | 129 | - | CTQ | Blood | No association. |
| rs6713532 | Intron | T > C | |||||||||
| rs6545975 | Intron | C > A | |||||||||
| rs934778 | Intron | A > G | |||||||||
AD, alcohol-dependent; BD, bipolar disorder; DE, depression; MDD, major depression disorder; PTSD, post-traumatic stress disorder; SA, suicide attempt; SB, suicide behavior; SI, suicide ideation; SP, suicide plan; CS, completed suicide; SUD, substance use dependence; SD, schizoaffective disorder; SZ, schizophrenia; BLEQ, Brief Life Events Questionnaire; ELES, Early Life Events Scale; ACE, Adverse Childhood Experiences Questionnaire; CTQ, Childhood Trauma Questionnaire; LEC, Life Events Checklist; SLEI, Stressful Life Event Inventory.
Characteristics of the included publications that evaluated HPA genes expression (mRNA) in the pathogenesis of suicide behavior.
| Author, Year | Suicide Behavior | N | Ethinicity | Tissue Source | Expression | Variant | Genotype/Expression | Trauma Exposure | Cortisol Concentrations |
|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
| McGowan, P. 2009 [ | CS | CS: 24 Controls:12 | Caucasian | Brain | ↓ | - | - | mRNA was significantly reduced in SV with a history of childhood abuse relative to non-abused SV | - |
| Sinclair, D. 2012 [ | CS | CS: 21, Controls: 34 | Caucasian | Brain | ↓ | rs10052957 | rs10052957, rs6190, rs41423247 ↓ | - | - |
| Pérez-Ortiz, J. M. 2013 [ | CS | CS: 13 Controls: 13 | Caucasian | Brain | ↓ | - | - | - | - |
| Zhao, J. 2015 [ | CS | CS: 17 Controls: 7 | Caucasian | Brain | No changes | - | - | - | - |
| Yin, H. 2016 [ | CS | CS: 21, Controls: 38 | European | Brain | ↓ | rs6196 | No association. | - | - |
| Roy, B. 2017 [ | SI | SI: 14, Controls: 20 | Caucasian and African-American | Blood | ↓ | - | - | - | - |
| Melhem, N. M. 2017 [ | SA and SI | SA:38, SI:40, Controls:37 | Caucasian | Blood | SA ↓ | - | - | mRNA was significantly and negatively associated with childhood abuse. | HCC was associated with mRNA. |
| Chang, H. B. 2019 [ | SA and SI | SA:38, SI:40, Controls:37 | Caucasian | Blood | No changes | - | - | - | No association. |
|
| |||||||||
| Pérez-Ortiz, J. M. 2013 [ | CS | CS: 13 Controls: 13 | Caucasian | Brain | ↓ | - | - | - | - |
| Yin, H. 2016 [ | CS | CS: 21 Controls: 38 | European | Brain | ↓ | rs3800373 | No association | - | - |
| Roy, B. 2017 [ | SI | SI: 14 Controls: 20 | Caucasian and African-American | Blood | ↓ | - | - | - | - |
| Melhem, N. M. 2017 [ | SA and SI | SA:38; SI:40 | Caucasian | Blood | SI ↓ | - | - | No association. | No association. |
| Chang, H. B. 2019 [ | SA and SI | SA:38; SI:40 Controls:37 | Caucasian | Blood | mRNA was consistently correlated with heroin, painkillers, and ecstasy use. | - | - | - | No association. |
|
| |||||||||
| Hiroi, N. 2001 [ | CS | CS: 9 | Caucasian | Brain | No change | - | - | - | - |
| Merali, Z. 2004 [ | CS | CS: 12 | Caucasian | Brain | ↓ | - | - | - | - |
| Zhao, J. 2015 [ | CS | CS: 17 | Caucasian | Brain | No change | - | - | - | - |
| Roy, B. 2017 [ | CS | CS: 14 | Caucasian and African-American | Blood | No change | - | - | - | - |
|
| |||||||||
| Hiroi, N. 2001 [ | CS | CS: 9 controls: 7 | Caucasian | Pituitary | No change | - | - | - | - |
| Merali, Z. 2004 [ | CS | CS: 12 Controls: 12 | Caucasian | Brain | No change | - | - | - | - |
| Zhao, J. 2015 [ | CS | CS: 17 Controls: 7 | Caucasian | Brain | No change | - | - | - | - |
|
| |||||||||
| Merali, Z. 2004 [ | CS | CS: 12 Controls: 12 | Caucasian | Brain | No change | - | - | - | - |
| Zhao, J. 2015 [ | CS | CS: 17 Controls: 7 | Caucasian | Brain | No change | - | - | - | - |
| Roy, B. 2017 [ | SI | SI: 14 Controls: 20 | Caucasian and African-American | Blood | No change | - | - | - | - |
|
| |||||||||
| Merali, Z. 2004 [ | CS | CS: 12 Controls: 12 | Caucasian | Brain | ↑ | - | - | - | - |
| Zhao, J. 2015 [ | CS | CS: 17 Controls: 7 | Caucasian | Brain | ↑ | - | - | - | - |
|
| |||||||||
| Yin, H. 2016 [ | CS | CS: 21 Controls: 38 | European | Brain | ↓ | rs8082544 | AG ↓ | - | - |
| rs7502947 | AG ↓ | ||||||||
| Pandey, G.N 2016 [ | CS | CS: 52 Control: 51 | Caucasian | Brain | ↓ | - | - | - | |
| Melhem, N. M. 2017 [ | SA and SI | SA:38, SI:40, Controls:37 | Caucasian | Blood | SI ↑ | - | - | No association. | No association. |
| Chang, H. B. 2019 [ | SA and SI | SA:38, SI:40, Controls:37 | Caucasian | Blood | Not changes | - | - | - | No association. |
↑, high expression; ↓, reduced expression; SA, suicide attempt; SI, suicide ideation; CS, completed suicide; HCC, hair cortisol concentration.
NOS scores of 41 studies included in the systematic review.
| Study | Year | Selection | Comparability | Outcome/Exposure | Score |
|---|---|---|---|---|---|
| Hiroi, N. [ | 2001 | ★★★ | ★ ★ | ★★ | 7 |
| Merali, Z. [ | 2004 | ★★★ | ★ ★ | ★★ | 7 |
| Papiol, S. 2007 [ | 2007 | ★★ | ★ ★ | ★★ | 6 |
| Wasserman, D. [ | 2008 | ★★ | ★ ★ | ★ ★ ★ | 7 |
| Willour, V. L. [ | 2009 | ★★★ | ★ ★ | ★★ | 7 |
| Wasserman, D. [ | 2009 | ★★ | ★ ★ | ★ ★ ★ | 7 |
| McGowan, P. [ | 2009 | ★★ | ★ ★ | ★ ★ ★ | 7 |
| De Luca, V. [ | 2010 | ★★★★ | ★ ★ | ★★ | 8 |
| Brent, D. [ | 2010 | ★★★ | ★ ★ | ★★ | 7 |
| Roy, A. [ | 2010 | ★★★★ | ★ ★ | ★★ | 8 |
| Perroud, N. [ | 2011 | ★ ★ | ★ ★ | ★ ★ | 6 |
| Supriyanto, I. [ | 2011 | ★ ★ ★ ★ | ★ ★ | ★ ★ | 8 |
| Ben-Efraim, Y. J. [ | 2011 | ★ ★ ★ | ★ ★ | ★★ | 7 |
| Sinclair, D. [ | 2012 | ★ ★ | ★ ★ | ★★ | 6 |
| Roy, A. [ | 2012 | ★★★ | ★ ★ | ★ ★ | 7 |
| Guillaume, S. [ | 2013 | ★ ★ | ★ ★ | ★ ★ | 6 |
| Leszczynska-Rodziewicz, A. [ | 2013 | ★ ★ | ★ ★ | ★ ★ | 6 |
| Pérez-Ortiz, J. M. [ | 2013 | ★ ★ ★ ★ | ★ ★ | ★ ★ | 8 |
| Leszczynska-Rodziewicz, A. [ | 2014 | ★ ★ | ★ ★ | ★ ★ | 6 |
| Zhao, J. [ | 2015 | ★★ | ★ ★ | ★ ★ | 6 |
| Breen, M. E. [ | 2015 | ★★★ | ★ ★ | ★★ | 7 |
| Fudalej, S. [ | 2015 | ★★ | ★ ★ | ★★ | 6 |
| Kaminsky, Z. [ | 2015 | ★★★ | ★ ★ | ★★ | 7 |
| Park, S. [ | 2016 | ★★★ | ★ ★ | ★★ | 7 |
| Breen, M. E. [ | 2016 | ★★★★ | ★ ★ | ★★ | 8 |
| Pawlak, J. [ | 2016 | ★★★★ | ★ ★ | ★★ | 8 |
| Pandey, G.N [ | 2016 | ★★★★ | ★ ★ | ★★ ★ | 9 |
| Sadeh, N. [ | 2016 | ★ ★ | ★ ★ | ★ ★ | 6 |
| Yin, H. [ | 2016 | ★★★★ | ★ ★ | ★★ | 8 |
| Mirkovic, B. [ | 2017 | ★★★ | ★ ★ | ★★★ ★ | 9 |
| Roy, B. [ | 2017 | ★★★ | ★ ★ | ★★ | 7 |
| Bastos, C. R. [ | 2017 | ★★★★ | ★ ★ | ★★★ | 9 |
| Melhem, N. M. [ | 2017 | ★★★ | ★ ★ | ★★★ | 8 |
| Ludwig, B. [ | 2018 | ★ ★ | ★ ★ | ★★★ | 7 |
| Chang, H. B. [ | 2019 | ★★ | ★ ★ | ★★★ | 7 |
| Sanabrais-Jiménez, M.A. [ | 2019 | ★★ | ★ ★ | ★★ | 6 |
| Segura, A. G. [ | 2019 | ★★ | ★ ★ | ★★ | 6 |
| Zhang, L. [ | 2019 | ★★★ | ★★ | ★★ | 7 |
| Nobile, B. [ | 2020 | ★★★ | ★ ★ | ★★ | 7 |
| Berent, D. [ | 2020 | ★★★★ | ★ ★ | ★★ ★ | 9 |
| Hernández-Díaz, Y. [ | 2021 | ★★★ | ★ ★ ★ | ★★ ★ | 9 |
The NOS scale range from zero to nine, giving a point (star) to each accomplished item, categorizing the studies as high quality (score 7–9), moderate quality (score 4–6), or poor quality (score 0–3).